CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Unexpected increase of Hepatitis B Surface Antigen (HBsAg) levels during treatment with nucleos(t)ide analogous 12–24 months before virological breakthrough and resistance
DOI 10.1055/s-0031-1295950
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Wiegand, J Jaroszewicz, B Zacher, K Wursthorn, K Deterding, MP Manns, H Wedemeyer, M Cornberg
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: HBsAg levels differ in the course of chronic hepatitis B virus infection and may predict the response to treatment with interferon alpha. Recently, we have shown that significant HBsAg decline during treatment with nucleos(t)ide analogues (NA) is associated with later HBsAg loss (Jaroszewicz et al., AVT 2011; GASL 2011). So far there is little data if resistance to NA affects HBsAg levels. Methods: In…
Zitieren
Zitierempfehlung
S Wiegand, J Jaroszewicz, B Zacher, K Wursthorn, K Deterding, MP Manns, H Wedemeyer, M Cornberg (2012) Unexpected increase of Hepatitis B Surface Antigen (HBsAg) levels during treatment with nucleos(t)ide analogous 12–24 months before virological breakthrough and resistance. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0031-1295950
Mit CareLit weiterarbeiten